Blinatumomab demonstrates superior efficacy compared to chemotherapy in children and young adults with relapsed B-ALL

Bookmark and Share
Published: 10 Dec 2019
Views: 446
Rating:
Save
Dr Patrick Brown - Johns Hopkins University, Baltimore, USA

Dr Patrick Brown presents data at ASH 2019 showing the improved survival of children and young adults with relapsed B-cell acute lymphoblastic leukaemia (B-ALL) when they were given blinatumomab compared with standard chemotherapy.  

Watch our interview with Dr Brown here

Read more about the study here